Vision and Mission

SINGAPORE SCIENCES is a pioneering biopharmaceutical leader dedicated to transforming healthcare through research-driven, clinically tested solutions for chronic diseases. With a robust portfolio and cutting-edge pipeline spanning endocrinology, immunology, and oncology, we leverage the most advanced innovations to develop premium therapeutic products.
Our mission is to redefine how diseases like diabetes, immune deficiencies, and cancer are prevented and treated, delivering hope and improved outcomes to patients worldwide.

Built upon a foundation grounded in scientific evidence, 
​SINGAPORE SCIENCES is recognized as the leader in the field of novel healthcare research & product developments. 

Each year SINGAPORE SCIENCES sponsors numerous research projects in leading institutes in Singapore and internationally on cutting edge research, including double-blind, placebo-controlled studies proving the safety and efficacy of its premier products.

Founders' Background

Patrick H.M. Loh

HonDSc, BBM, PBM

Professor Patrick H.M. Loh

HonDSc, BBM, PBM

Singapore Distinguished Professor (Murdoch University, Australia)
Chartered Horticulturist, C Hort (UK)
Chartered Fintech Professional (CFtP)

Cofounder & Chairman

Professor Loh is Chairman & Co-Founder of SINGAPORE SCIENCES and SINOAGRO GROUP. A practising plant scientist, Professor Loh is one of the early pioneering bio-entrepreneurs in Singapore who successfully established the commercial application of biological and molecular techniques to plant and crop improvements in the agro-based industries in the ASEAN region.

read more

​Professor Patrick H.M. Loh is Chairman and Co-Founder of SINGAPORE SCIENCES and SINOAGRO GROUP.  Professor Loh’s distinguished and illustrious career spanned more than two decades both in the academic and corporate world, where he is a professor, chairman and advisor in many institutions and organisations.

read more

Mr P.F. Chang

B.Eng (Bioengineering),
Chartered Engineer, CEng (UK)

Cofounder & CEO

Mr Chang holds a Bachelor of Engineering degree with a Major in Bioengineering from Nanyang Technological University (NTU) in Singapore. In 2010, he established his first agrobiotech company to produce and supply biotech-derived therapeutic materials to healthcare corporations in Singapore. In 2012, he formulated and secured CPM approval from the Health Sciences Authority (HSA) of Singapore for the first High Active Ingredient Certified-Organic Cordyceps capsule product and trademarked in Singapore (2012).

read more

​Mr P.F. Chang graduated with a Bachelor of Engineering, Major in Bioengineering from the Nanyang Technological University (NTU) in Singapore. Whilst reading for his Bachelor’s degree, he was one of the few undergraduates selected to join the Bioengineered & Applied Nanomaterials Laboratory in NTU to undertake drug formulation/delivery project pertaining to the investigation of ‘Protein Nanocages’.

read more

DR .Tan Chee Eng

SINGAPORE SCIENCES Medical Specialist Adviser

Consultant Physician & Endocrinologist MBBA, MMed (Int Med) FAMS (S'pore), PhD (Glasgow)

Dr Tan Chee Eng is Consultant Endocrinologist at the renowned Gleneagles Medical Centre in Singapore. Before starting private practice at Gleneagles Medical Centre in 2004, he was the Head of Department of Endocrinology at the Singapore General Hospital (SGH) for 5 years. Whilst at SGH, he was responsible for starting up the first Lipid unit in Singapore and also pioneered the electronic medical record for diabetes mellitus consultation (DMCARE).

read more

SINGAPORE SCIENCES Medical Specialist Adviser

Consultant Physician & Endocrinologist

MBBA, MMed (Int Med)

FAMS (S'pore), PhD (Glasgow)

Medical education

Dr Tan Chee Eng is Consultant Endocrinologist at the renowned Gleneagles Medical Centre in Singapore. Before starting private practice at Gleneagles Medical Centre in 2004, he was the Head of Department of Endocrinology at the Singapore General Hospital (SGH) for 5 years. Whilst at SGH, he was responsible for starting up the first Lipid unit in Singapore and also pioneered the electronic medical record for diabetes mellitus consultation (DMCARE).

Endocrinologist expertise

Dr Tan's medical career began in 1984 when he graduated with the Bachelor of Medicine & Surgery from the National University of Singapore (NUS). Following that, he completed his Masters in Internal Medicine at NUS and PhD at the University of Glasgow, United Kingdom.

Prolific researcher

He is currently a member of the Lipid Guidelines committee, Ministry of Health (MOH), Singapore. He is a founder member and member of the Executive Council for the Asian Pacific Society of Atherosclerosis and Vascular Disease since 1999. He is currently also on the executive committee, Regional Federation for Asia Pacific, International Atherosclerosis Society. He was previously involved in both the Lipid Guidelines and Diabetes guidelines committee of the Ministry of Health (MOH), Singapore. He was also a member of the Singapore Ministry of Health taskforce on obesity. Other past appointment includes Adjunct Associate Professor with the Centre for Molecular Epidemiology, National University of Singapore (NUS).

Consultant endocrinologist

​Dr Tan is a practising endocrinologist and has been managing patients with diabetes mellitus, cholesterol problems and obesity for the past 25 years. Therefore he is a firm believer in the benefits of exercise, nutrition and lifestyle changes in management of chronic metabolic diseases.

He has published more than 90 articles in International peer-reviewed journals and spoken at more than 300 international and local symposiums. He was also on the International Steering committee of a few international collaborative studies on risk factors for heart disease and diabetes mellitus.

Our R&D Initiatives and Collaborators

Advisory Board Members

Update currently in progress…

 

 

SINGAPORE SCIENCES is a biopharmaceutical company that develops research-based, clinically tested healthcare products that addresses chronic diseases. Our portfolio and pipeline spanning endocrinology (diabetes), immunology and oncology, our goal is to use the most innovative approach in developing therapeutic products of the highest quality, to change the way how diseases such as diabetes, immune deficiencies and cancer are prevented and treated.

Each year SINGAPORE SCIENCES sponsors numerous research projects in leading institutes in Singapore and internationally on cutting edge research, including double-blind, placebo-controlled studies proving the safety and efficacy of its premier products.

Built upon a foundation grounded in scientific evidence, SINGAPORE SCIENCES is recognized as the leader in the field of novel healthcare research & product developments.

Our Research Areas

Lorem ipsum dolor sit amet, consectetur adipiscing elit pellentesque lectus.

read more

Featured Products

Lorem ipsum dolor sit amet, consectetur adipiscing elit pellentesque lectus.

read more

Shop

Lorem ipsum dolor sit amet, consectetur adipiscing elit pellentesque lectus.

read more